BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 18728033)

  • 61. Anti-inflammatory effects of Artemisia princeps in antigen-stimulated T cells and regulatory T cells.
    Chang SH; Jung EJ; Park YH; Lim DG; Ko NY; Choi WS; Her E; Kim SH; Choi KD; Bae JH; Kim SH; Kang CD; Han DJ; Kim SC
    J Pharm Pharmacol; 2009 Aug; 61(8):1043-50. PubMed ID: 19703348
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning.
    Chang L; Chang WC; McNamara G; Aguilar B; Ostberg JR; Jensen MC
    Cytotherapy; 2007; 9(8):771-84. PubMed ID: 17917884
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cytotoxic difference of T cells expanded with anti-CD3 monoclonal antibody in the presence and absence of anti-CD 28 monoclonal antibody.
    Yamada-Ohnishi Y; Azuma H; Urushibara N; Yamaguchi M; Fujihara M; Kobata T; Ikeda H
    Stem Cells Dev; 2004 Jun; 13(3):315-22. PubMed ID: 15186727
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Optimization of in vitro expansion of macaque CD4 T cells using anti-CD3 and co-stimulation for autotransfusion therapy.
    Onlamoon N; Hudson K; Bryan P; Mayne AE; Bonyhadi M; Berenson R; Sundstrom BJ; Bostik P; Ansari AA; Villinger F
    J Med Primatol; 2006 Aug; 35(4-5):178-93. PubMed ID: 16872281
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
    Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
    J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells.
    Paine A; Oelke M; Blasczyk R; Eiz-Vesper B
    Transfusion; 2007 Nov; 47(11):2143-52. PubMed ID: 17958544
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-CD3 scFv-B7.1 fusion protein expressed on the surface of HeLa cells provokes potent T-lymphocyte activation and cytotoxicity.
    Yang ZM; Li EM; Lai BC; Wang YL; Si LS
    Biochem Cell Biol; 2007 Apr; 85(2):196-202. PubMed ID: 17534400
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Products of anti-CD3/anti-CD28 activated lymphocytes induce differentiation and maturation of dendritic cells and have adjuvant-like activity in vitro and in vivo.
    Harris KM; Lenz P; Hankey KG; MacVittie T; Farese A; Nakajima K; Hasumi K; Mann DL
    Clin Immunol; 2008 Oct; 129(1):58-68. PubMed ID: 18691939
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ligation of CD3 triggers transmembrane proximity between LFA-1 and cortical microfilaments in a cytotoxic T cell clone derived from tumor infiltrating lymphocytes: a quantitative resonance energy transfer microscopy study.
    Poo H; Fox BA; Petty HR
    J Cell Physiol; 1994 Apr; 159(1):176-80. PubMed ID: 8138585
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correlation of effector function with phenotype and cell division after in vitro differentiation of naive MART-1-specific CD8+ T cells.
    Casado JG; DelaRosa O; Pawelec G; Peralbo E; Duran E; Barahona F; Solana R; Tarazona R
    Int Immunol; 2009 Jan; 21(1):53-62. PubMed ID: 19050104
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of T-cell response to CD3 plus CD28 monoclonal antibodies in HIV-1 infected subjects treated with highly active antiretroviral therapy.
    Carlesimo M; Bernardi ML; Mattiacci G; Pierdominici M; Ferrara R; Donnanno S; Alario C; Aiuti F
    J Biol Regul Homeost Agents; 2000; 14(1):38-40. PubMed ID: 10763891
    [TBL] [Abstract][Full Text] [Related]  

  • 73. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
    Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Optimizing anti-CD3 affinity for effective T cell targeting against tumor cells.
    Bortoletto N; Scotet E; Myamoto Y; D'Oro U; Lanzavecchia A
    Eur J Immunol; 2002 Nov; 32(11):3102-7. PubMed ID: 12385030
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
    Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
    Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
    [TBL] [Abstract][Full Text] [Related]  

  • 76. T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.
    Lamers CH; van Steenbergen-Langeveld S; van Brakel M; Groot-van Ruijven CM; van Elzakker PM; van Krimpen B; Sleijfer S; Debets R
    Hum Gene Ther Methods; 2014 Dec; 25(6):345-57. PubMed ID: 25423330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
    Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
    Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cells.
    Numbenjapon T; Serrano LM; Chang WC; Forman SJ; Jensen MC; Cooper LJ
    Exp Hematol; 2007 Jul; 35(7):1083-90. PubMed ID: 17588477
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular mechanisms for Kv1.3 potassium channel current inhibition by CD3/CD28 stimulation in Jurkat T cells.
    Matsushita Y; Ohya S; Itoda H; Kimura T; Suzuki Y; Yamamura H; Imaizumi Y
    Biochem Biophys Res Commun; 2008 Sep; 374(1):152-7. PubMed ID: 18611390
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma.
    Campillo JA; Martínez-Escribano JA; Minguela A; López-Alvarez R; Marín LA; García-Alonso AM; Bensussan A; Alvarez-López MR
    Dermatology; 2007; 214(4):283-8. PubMed ID: 17460398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.